Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

Rhea-AI Summary

Weight Watchers (NASDAQ: WW) announced a strategic partnership with PVOLVE on February 10, 2026 to add clinically validated strength, mobility, and stability workouts into Weight Watchers programs. The collaboration integrates PVOLVE classes into Core, Core+, Med+, GLP-1 Success and Menopause tracks, offers a 1,700+ on-demand library at reduced rates, and a curated starter kit. Company data cites Med+ members engaged with the program lost 61.3% more weight at one month and 29.1% more at 12 months versus medication alone; a 12-week PVOLVE program showed 19% improved lower-body strength.

Positive

• Med+ members achieved 61.3% more weight loss at one month
• Med+ members achieved 29.1% more weight loss at 12 months
• PVOLVE 12-week program produced 19% improvement in lower-body strength
• Access to a 1,700+ on-demand PVOLVE class library through Weight Watchers

Negative

• None.

Key Figures

Med+ 1-month weight loss uplift: 61.3% more body weight lost Med+ 12-month weight loss uplift: 29.1% more body weight lost Age-related muscle loss: 3–5% per decade +3 more

6 metrics

Med+ 1-month weight loss uplift 61.3% more body weight lost Engaged Med+ members vs medicine alone at 1 month

Med+ 12-month weight loss uplift 29.1% more body weight lost Engaged Med+ members vs medicine alone at 12 months

Age-related muscle loss 3–5% per decade Typical female muscle mass loss starting at age 30

PVOLVE program duration 12 weeks Clinically studied PVOLVE workout program

Lower body strength gain 19% improvement Participants in 12-week PVOLVE program

PVOLVE class library 1,700+ on-demand classes Expanded PVOLVE streaming accessible via WW app

Market Reality Check

Price: $23.78 Vol: Volume 761,126 is 2.19x t...

high vol

$23.78 Last Close

Volume Volume 761,126 is 2.19x the 20-day average of 346,987, indicating elevated interest ahead of/around this partnership release. high

Technical Shares at 24.28 are trading above the 200-day MA of 22.78, reflecting a pre-existing upward bias into this news.

Peers on Argus

WW gained 10.92% while key peers were mixed to flat: RGS up 2.97%, CSV down 1.08...

WW gained 10.92% while key peers were mixed to flat: RGS up 2.97%, CSV down 1.08%, MED down 0.18%, and others unchanged. This pattern points to a WW-specific reaction rather than a broad personal-services move.

Previous Partnership Reports

2 past events · Latest: Oct 20 (Positive)

Same Type Pattern 2 events

Date	Event	Sentiment	Move	Catalyst
Oct 20	Pharmacy collaboration	Positive	+9.3%	Partnered with Amazon Pharmacy to speed and simplify medication access.
May 01	Employer partnership	Positive	+1.1%	Teamed with Personify Health to bring WW weight-health solutions to employers.

Pattern Detected

Partnership announcements have previously coincided with positive single-day moves for WW.

Recent Company History

Over the past year, WW has repeatedly used partnerships to deepen its weight-health ecosystem. On Oct 20, 2025, it collaborated with Amazon Pharmacy to streamline medication delivery for Clinic members, and the stock rose 9.25%. On May 1, 2024, a business-focused partnership with Personify Health to reach employers saw a 1.1% gain. Today’s PVOLVE collaboration extends this pattern by adding strength-focused fitness content alongside WW’s GLP‑1 and behavioral offerings.

Historical Comparison

partnership

+5.2 %

Average Historical Move

Historical Analysis

In the past, WW partnership announcements averaged a 5.17% move. Today’s 10.92% gain on the PVOLVE deal sits notably above that typical reaction range.

Typical Pattern

Recent partnerships have expanded WW’s ecosystem across medication delivery, employer channels, and now strength-focused fitness, reinforcing its integrated GLP‑1-centric weight-health strategy.

Market Pulse Summary

This announcement adds a clinically validated strength-training component to WW’s GLP‑1 era strategy...

Analysis

This announcement adds a clinically validated strength-training component to WW’s GLP‑1 era strategy by integrating PVOLVE content into core programs. The data cited—such as 61.3% and 29.1% greater weight loss with Med+ support and a 19% strength gain in a 12‑week PVOLVE program—highlights WW’s emphasis on combining medication, behavior change, and muscle preservation. Investors may watch future updates on member engagement, outcomes, and potential new partnerships.

Key Terms

glp-1, perimenopause, menopause

3 terms

glp-1 medical

"As weight health enters a new era driven by GLP-1 medications..."

GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.

perimenopause medical

"specialized series for women in perimenopause and menopause..."

The phase leading up to menopause when a person’s hormone levels and menstrual cycles change, causing symptoms such as hot flashes, sleep disruption, mood shifts and irregular periods. Investors track perimenopause because it drives demand for medical treatments, over-the-counter products, workplace accommodations and health services—think of it like a market-shaping shift in customer needs and labor productivity as a population moves from one long-term life stage to another.

menopause medical

"specialized series for women in perimenopause and menopause..."

Menopause is the natural stage in a person’s life when menstrual periods stop permanently because the ovaries reduce production of hormones like estrogen and progesterone; it is typically diagnosed after 12 consecutive months without a period. Investors care because menopause drives demand for medical treatments, diagnostic services, over‑the‑counter products and workplace accommodations, similar to a market shift when a large customer group changes its needs, affecting revenue and product strategies across health, consumer and employer sectors.

AI-generated analysis. Not financial advice.

The new partnership combines Weight Watchers’ scientifically-backed medical and behavioral expertise with PVOLVE’s clinically-studied method to support members at every age and stage of life

NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced a strategic partnership with PVOLVE, the clinically validated workout method, designed to support longevity through strength, mobility, and stability training.

As weight health enters a new era driven by GLP-1 medications and growing awareness of the role lean muscle plays in metabolism, Weight Watchers continues to innovate its science-backed approach to deliver even stronger outcomes for members. Building and preserving muscle plays an important role in long-term health, especially for women in midlife and members using GLP-1 medications.

To meet these evolving needs, Weight Watchers is further expanding its integrated approach by deepening its strength-forward movement offerings through PVOLVE’s clinically validated method to support members throughout their weight health journey and promote overall longevity.

Starting today, Weight Watchers members will gain access to exclusive PVOLVE classes suitable for all fitness levels and life stages through the WeightWatchers Core, Core+, Med+, GLP-1 Success and Menopause programs. Members will also be able to upgrade to PVOLVE’s full on-demand library through Weight Watchers and purchase a curated starter kit featuring PVOLVE’s best-selling unique resistance equipment.

For members using GLP-1 medications, strength training plays a critical role in supporting lean muscle and long-term success. The Weight Watchers Med+ Program, which includes their GLP-1 Success Program combines board-certified clinicians, behavioral science, personalized nutrition, strength-building plans, and expert coaching and community support to help manage side effects and deliver better outcomes than medication alone.

Data shows the positive impact of this integrated approach. At one month, regularly engaged Weight Watchers Med+ members lost 61.3% more body weight than those who took medicine alone; and at twelve months, 29.1% more.

Women lose 3-5% of muscle mass per decade, starting at age 30, but PVOLVE’s workouts have been shown to help partially offset this decline. In a 12-week PVOLVE program, participants experienced significant increases in lean muscle mass and improved lower body strength by 19%.

By pairing Weight Watchers’ holistic approach to nutrition, behavior change support, and medical care with PVOLVE’s fitness method, members receive a more personalized and comprehensive approach to weight health.

"As the definition of weight health evolves, so does our approach,” said Julie Rice, Chief Experience Officer of Weight Watchers. “This partnership with PVOLVE builds on our foundation by bringing more strength-forward movement into our ecosystem alongside nutrition, behavior change, coaching, and medical care - so our members can achieve more sustainable, long-term results."

“Movement should empower you, not exhaust you,” said Rachel Katzman, Founder of PVOLVE. “PVOLVE was created to help people feel strong, capable, and confident in their bodies through every stage of life, and we saw a natural partnership with Weight Watchers in that shared vision. For more than six decades, they’ve supported millions of people with a science-backed, comprehensive approach to health, and together we’re bringing movement, nutrition, medical care and coaching together in a way that truly supports real, lasting change and longevity.”

What Members Receive Through Weight Watchers + PVOLVE Partnership:
As part of the collaboration, all Weight Watchers members will gain access to exclusive benefits from PVOLVE, including:

• Weight Watchers + PVOLVE Streaming Membership: Immediate access to select custom PVOLVE workouts through the Weight Watchers app – designed for all fitness levels and life stages, with specialized series for women in perimenopause and menopause, and a dedicated GLP-1 strength series.
• Expanded PVOLVE streaming experience: The opportunity to unlock the full PVOLVE library of 1,700+ on-demand classes through the Weight Watchers app at a special reduced member rate.
• Weight Watchers + PVOLVE Starter Kit: A curated kit featuring PVOLVE’s best-selling essentials, which include – Gliders, Floor Gloves, Heavy Ankle Band, P.ball, and P.band, also at a reduced member rate.
  
  

As weight health solutions become increasingly fragmented, Weight Watchers is setting the industry standard by delivering a fully integrated experience that unites medical care, nutrition, behavior change, and movement in one connected platform. The partnership with PVOLVE builds on this foundation to further recognize strength, mobility, and muscle preservation as essential contributing pillars of lasting weight health.

ABOUT WEIGHT WATCHERS
Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.

ABOUT PVOLVE
PVOLVE is the first clinically-proven movement longevity company- built on a method that uniquely combines the three pillars of longevity training: strength, mobility, and stability. Using patented resistance equipment and functional movement patterns, PVOLVE sculpts and tones the body while helping members move better, longer. Founded by Rachel Katzman in 2017, the PVOLVE Method is backed by a Clinical Advisory Board of expert physicians and highly credentialed trainers with expertise in human physiology and biomechanics. In June 2023, world-renowned actress Jennifer Aniston officially partnered with PVOLVE after experiencing transformative results, calling the method “a game changer” for how she felt and looked. PVOLVE has a hybrid fitness model, offering more than 1,700 on-demand workouts, a two-way live virtual studio, and targeted series across web and mobile apps. The brand has over 30 studio locations open across North America, with more than 50 additional studios in development. Learn more at pvolve.com and pvolvefranchise.com.

For media inquiries, please contact:
Lizzy Levitan 
WW@hunt-gather.com

For investor inquiries, please contact:
John Mills or Anna Kate Heller
WeightWatchers@icrinc.com

FAQ

What does the Weight Watchers and PVOLVE partnership announced Feb 10, 2026 (WW) offer members?

It provides immediate access to exclusive PVOLVE workouts and a discounted full library. According to the company, members can access select custom classes in-app, unlock 1,700+ on-demand sessions at reduced rates, and buy a curated starter kit with PVOLVE resistance equipment.

How does the partnership affect Weight Watchers Med+ and GLP-1 Success program outcomes for WW members?

It aims to boost strength and weight-loss outcomes when combined with medication. According to the company, engaged Med+ members lost 61.3% more weight at one month and 29.1% more at 12 months compared with medication alone.

What clinical fitness results support adding PVOLVE to Weight Watchers programs (WW)?

PVOLVE clinical data showed measurable strength and lean-mass benefits in short programs. According to the company, a 12-week PVOLVE program increased lower-body strength by 19% and produced significant lean muscle mass gains.

Which Weight Watchers plans include PVOLVE content and who can use it (WW)?

PVOLVE content is available across core and specialty Weight Watchers plans. According to the company, Core, Core+, Med+, GLP-1 Success, and Menopause programs include exclusive PVOLVE classes suitable for all fitness levels and life stages.

Can Weight Watchers members access PVOLVE’s full on-demand library and equipment through WW?

Yes; members may unlock the entire PVOLVE library and purchase equipment at reduced rates. According to the company, members can upgrade to the full 1,700+ on-demand PVOLVE catalog and buy a starter kit with curated resistance tools.